New wearable could double diabetes monitoring power
NCT ID NCT07139808
First seen Apr 18, 2026 · Last updated Jun 23, 2026 · Updated 14 times
Summary
This study is testing a new wearable device that continuously measures both glucose (sugar) and ketone levels in adults with type 1 diabetes. The device is worn for 15 days and its readings are compared to standard lab tests. The goal is to see if it is accurate and safe enough for everyday use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE1DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Henan University of Science and Technology
RECRUITINGLuoyang, Henan, 471003, China
Contact Email: •••••@•••••
-
The First Hospital of Hebei Medical University
RECRUITINGShijiazhuang, Hebei, 050000, China
Contact Phone: •••-•••-••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GK5 CGKM (continuous glucose and ketone monitoring device)
What this could lead to
If successful, this could provide a more accurate and convenient way for people with type 1 diabetes to monitor both glucose and ketone levels, potentially improving daily disease management.
What could go wrong
This is a very small, early-stage study with only 12 participants, focused on accuracy and safety rather than health outcomes. The device may not prove significantly better than existing monitors, and results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.